HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polyethylene wear and osteolysis is associated with high revision rate of a small sized porous coated THA in patients with hip dysplasia.

Abstract
The outcome of 25 primary THAs in patients with hip dysplasia using the AML Bantam femoral stem (DePuy) is reported. Age at operation averaged 43 ± 10 years. Twenty-two of 25 stems were cementless. All cementless acetabular components had conventional or cross-linked polyethylene and screws. Follow-up averaged 11 ± 5 years (range 4-18). Four cementless stems were revised after 3, 4, 8, and 9 years; 2/3 cemented stems were revised at 8 and 18 years. Femoral revisions demonstrated extensive conventional polyethylene wear, periprosthetic osteolysis and loosening. Five entire cups were revised for wear and loosening; four liners were replaced. Harris Hip Scores for patients with retained stems went from 43 ± 12 to 85 ± 13. High revision rates with the proximally porous coated Bantam stem are due to loss of fixation, often associated with polyethylene wear and osteolysis.
AuthorsPatrick J Murray, Katherine L Hwang, Susanna N Imrie, James I Huddleston 3rd, Stuart B Goodman
JournalThe Journal of arthroplasty (J Arthroplasty) Vol. 29 Issue 7 Pg. 1373-7 (Jul 2014) ISSN: 1532-8406 [Electronic] United States
PMID24698818 (Publication Type: Journal Article)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • Polyethylene
Topics
  • Adult
  • Aged
  • Arthroplasty, Replacement, Hip (adverse effects)
  • Bone Screws
  • Female
  • Femur (surgery)
  • Follow-Up Studies
  • Hip Dislocation (diagnostic imaging, etiology, surgery)
  • Hip Prosthesis (adverse effects)
  • Humans
  • Male
  • Middle Aged
  • Osteolysis (diagnostic imaging, etiology)
  • Polyethylene (chemistry)
  • Porosity
  • Prosthesis Design
  • Prosthesis Failure
  • Radiography
  • Reoperation
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: